Telehealth vs In-Person Treatment for OCD: What the Research Shows

You are making a decision you should not have to make alone. Your child or your partner or yourself has OCD, and the options include telehealth therapy that can begin within days from anywhere you have a phone signal, and a smaller number of specialty in-person programs that are harder to find and harder to schedule. You are exhausted from how long this has already taken, and the path of least resistance is the option that asks the least of you in the short run. You also suspect that the path of least resistance may not be the path that holds, and you do not have time to be wrong about this.

If this is your moment, the research has something useful to say, and the answer is not the same for every case. Telehealth and in-person treatment for OCD are different products, evidently, even when both are competently delivered, and the question of which one fits your situation depends on clinical factors that rarely get addressed in a side-by-side comparison. This article walks through what the literature actually shows, when each modality fits, and how to think about the structural-fit question that determines whether a treatment regimen has a real chance of working.

What the Research Actually Shows

The clearest piece of recent research-grounded framing on the modality question comes from a May 2026 piece by Behavioral Sciences of Alabama, an IOCDF-listed specialty Intensive Outpatient Program (IOP), drawing on the underlying NIH-indexed research on telehealth IOP for OCD. The piece summarizes COVID-era research finding that telehealth Intensive Outpatient Programs were effective but typically required about 2.6 additional treatment days on average to reach in-person outcomes, with severity and age limits on top of that. The findings are honest about telehealth's place, including that telehealth IOP works for some patients and is structurally different for others.

This is the practical state of the literature. Equivalence is not the right summary; "effective for some presentations, structurally limited for others" is. The research is also clear on a related point. The Exposure and Response Prevention (ERP) work that defines OCD treatment depends on exposure to the trigger, and when the trigger requires physical presence (in-vivo exposure in specific environments, contamination exposures that require physical contact, behavioral exposures that require the clinician to be in the room), telehealth cannot reach the trigger, evidently regardless of clinician skill.

Telehealth is a real treatment medium with a real role. It is not, however, a one-to-one substitute for in-person work for every case, and the structural-fit question is what determines whether a particular patient's regimen has a chance to work.

When Telehealth Fits the Case

Telehealth OCD therapy fits well in several specific situations, including:

• Maintenance phases of treatment after intensive specialty work has produced gains and the patient is consolidating skills
• Geographic access constraints where the closest specialty in-person program is too far to be feasible
• Mild-to-moderate presentations responsive to standard ERP at standard outpatient dosing
• Patients whose trigger lives where they live and whose home environment is conducive to exposures (a contamination patient whose trigger is in their kitchen can do meaningful ERP from the kitchen)
• Patients in stable life circumstances with adequate support and a quiet environment for sessions
• Cost and coverage situations where telehealth is what insurance will support and in-person specialty care would be prohibitive

For these presentations, telehealth therapy from a clinician with OCD-specific training can deliver meaningful, evidence-based ERP. The regimen is real. The skills utilized in this regimen include exposure planning, hierarchy building, and homework adherence, and a competent telehealth clinician can guide all three.

When In-Person Treatment Fits the Case

In-person treatment, particularly intensive in-person treatment, fits well in several other specific situations, including:

• Severe presentations across subtypes, including severe contamination, harm OCD, Just Right OCD, Pure O, scrupulosity, and others where the symptom intensity has impaired daily function
• Treatment-resistant presentations where prior modalities, including telehealth, have not held
• Co-occurring conditions complicating single-modality treatment, including anxiety, depression, BDD, eating disorders, and treatment-interfering behaviors
• Cases requiring in-vivo exposures that cannot be done over video, including exposures in public spaces, transit, specific physical environments, or contamination exposures requiring physical contact
• Patients whose home environment is part of the maintaining picture including family-system dynamics that need in-room work, environments that reinforce avoidance, home life that does not support consistent telehealth sessions
• Cases where the clinician-patient relationship needs in-room presence for the work to land, including high-anxiety patients who cannot tolerate exposure planning over video, patients who have difficulty engaging in the work without another person present, or patients with significant trust barriers that take in-person work to address

For these presentations, the structural difference is not subtle. The exposure work itself is constrained by the medium when the trigger requires physical presence, and a regimen that cannot reach the trigger cannot do its work. This is not, evidently, a criticism of telehealth clinicians. It is a recognition that the modality changes what becomes possible in the room.

Why the Modality Question Often Gets Asked Too Late

The conversation many patients have when they are first weighing treatment options goes something like this: their primary care provider mentions therapy, they look online, they find telehealth options that are immediately available, they begin, and somewhere between three and twelve months later they find themselves wondering whether this is the right treatment for their case. By the time the modality question is asked clearly, the patient has often already invested significant time, money, and emotional energy in the regimen that was easiest to start, and the cost of switching feels higher than it should.

The right time to ask the modality question is at the beginning. The right person to ask it of is a clinician who has an understanding of each presentation and who is not, evidently, attached to a particular answer. The structural-fit question is not "telehealth or in-person." It is "what does this specific case clinically require, and which modality can deliver it." A specialty evaluation can answer that question in a single conversation. A patient working through the question alone from a Google search is rarely getting the structural information that actually determines the answer.

What "Intensive" Actually Means Across Modalities

The label "intensive" has been applied to a wide range of products, including telehealth Intensive Outpatient Programs with 10 to 15 hours per week of video sessions delivered by a rotating clinician team, and in-person Intensive Outpatient Programs with 10 to 25 hours per week of one-on-one work delivered by a continuous specialty clinician. These are different products. The label is the same. The structural choices, including modality, continuity of clinician, in-vivo exposure capability, and hours-per-week scaling to case complexity, are not.

When a referring clinician or a family is choosing between programs labeled "intensive," the questions worth asking are specific. How many hours per week, and is the time one-on-one or supplemented by groups? Is the program in-person or telehealth, and what is the clinical reasoning for that modality choice in this particular case? What is the clinician-to-patient ratio? How is the exposure hierarchy built for the specific subtype that is driving the presentation? Programs that answer these questions specifically are signaling diagnostic rigor. Programs that answer them generically are signaling that the structural choices have not been made at the level of clinical specificity a complex case requires.

How Bio Behavioral Institute Thinks About Modality Fit

At Bio Behavioral Institute, under the clinical leadership of Dr. Fugen Neziroglu and a team that has been treating OCD presentations for over 45 years across more than 4,000 patients, modality choice is part of the treatment planning conversation rather than a single answer applied to every case. For severe and complex presentations, our in-person Intensive Outpatient Program (10 to 25 hours per week, one-on-one, in person) is the appropriate level of care, and we have repeatedly seen patients arrive after telehealth treatment that did not hold, where the structural-fit question had not been asked at intake. For maintenance phases after specialty work, telehealth can be part of step-down planning, and we collaborate with referring clinicians on continuity of care across the modality transition.

The honest framing for a patient or family is that the right answer is the one that fits the case, and the question worth asking before choosing a specific program is the modality question, and the question worth asking before the modality question is the structural-fit question. Programs that take the structural-fit question seriously will tell you when telehealth is the right answer for your case, and additionally will tell you when it is not.

Take the Next Step

If you are weighing telehealth and in-person treatment for OCD and you are not sure which one fits your situation, schedule a consultation at Bio Behavioral Institute by calling (516) 487-7116 to talk through what you have been experiencing and what an evidence-based treatment regimen would look like. No pressure, no commitment, just a conversation with a team that has been doing this work for over four decades. We do not push in-person care on patients whose case fits a less intensive regimen. We use the in-person model for the presentations that need it.

Frequently Asked Questions

Is telehealth as effective as in-person treatment for OCD?

For some presentations yes, for others no. Research from the COVID era found that telehealth IOP was effective but typically required about 2.6 additional treatment days on average to reach in-person outcomes, with severity and age limits on top of that. For mild-to-moderate presentations responsive to standard ERP, telehealth from an OCD-specialized clinician can produce comparable outcomes. For severe, treatment-resistant, or structurally complex presentations, the in-person model is often necessary because the exposure work itself requires physical presence.

How do I know whether my case needs in-person treatment?

The clinical factors that point toward in-person treatment include severity (high-functional-impairment presentations), prior treatment that has not held (especially prior ERP that did not produce durable change), co-occurring conditions complicating single-modality treatment, and the need for in-vivo exposures that cannot be done over video. A specialty evaluation can sort this out, and additionally can identify cases where the answer is actually a hybrid (telehealth maintenance after in-person intensive work).

Can I start with telehealth and step up if needed?

Yes, and this is a reasonable path for cases where the severity is unclear at intake. Step-up planning works well when the treating clinician is, evidently, prepared to recognize when the modality is not delivering and to refer for a higher level of care. The questions worth asking at intake include how the program handles step-up decisions and how they coordinate with specialty in-person clinics for the cases that need them.

What if I cannot travel to in-person treatment?

Geographic access is a real constraint. For some patients, the answer is telehealth from an OCD-specialized clinician, which can deliver real ERP within the structural limits described above. For others, a time-limited in-person intensive (a short stay during which the patient travels for treatment) followed by telehealth maintenance is the appropriate compromise. The right answer depends on the case complexity and what kinds of exposures the regimen requires.

How does a large telehealth program compare to a specialty in-person clinic?

They are different products. A large telehealth program offers wide geographic accessibility, broad insurance acceptance, and the visibility that makes many patients aware specialty OCD treatment exists at all. A specialty in-person clinic offers continuity of clinician, in-vivo exposure capability, hours-per-week scaling to the specific case, and the diagnostic rigor that comes from a team that has spent decades working with the full range of presentations. Both have real value. Neither one substitutes for the other across every case, and the question of which one fits your situation is worth taking seriously.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified mental health provider with any questions you may have regarding a medical condition. If you or someone you know is in crisis, please contact the 988 Suicide & Crisis Lifeline by calling or texting 988.